Brief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
21/05/2026 02:37
May 21 (Reuters) - Argenica Therapeutics Ltd AGN.AX: IND APPLICATION ADVANCED WITH SUCCESSFUL COMPLETION OF ASSAY COMPLETES FDA-REQUESTED GLP MOUSE LYMPHOMA ASSAY WITH NO EVIDENCE OF GENOTOXICITY TWO OF THREE FDA-REQUESTED ASSAYS COMPLETE; GLP HERG CARDIAC SAFETY ASSAY IN PROGRESS Further company coverage: AGN.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M